EBV LMP1 antibody (C-Term)
Quick Overview for EBV LMP1 antibody (C-Term) (ABIN870470)
Target
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 369-384, C-Term
-
Purpose
- Anti-EBV/LMP-1
-
Specificity
- EBV/LMP-1
-
Immunogen
- Peptide derived from the C-terminal region of Epstein-Barr virus (EBV), Latent Membrane Protein-1 (LMP-1). Antibody recognizes the epitope between Ser369 - Tyr384
-
Isotype
- IgG
-
-
-
-
Application Notes
- 1:100 - 200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 20 mM Tris-HCI, pH 8.0, Stabilizer: 20 mg/mL BSA, Preservative: 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- +2 °C to +8 °C
-
-
- EBV LMP1 (Epstein-Barr Virus Latent Membrane Protein 1 (EBV LMP1))
-
Alternative Name
- EBV/LMP-1
-
Target Type
- Viral Protein
-
Background
- Expression of EBV - LMP-1 protein induces changes associated with EBV infections and activation of primary B cells. LMP-1 belongs to the oncoproteins of the EBV latent gene product, expressed in the majority of the EBV-related human cancers and infectious mononucleosis.
-
UniProt
- P03230
Target
-